NIH Group Proposes Ventricular Assist Study For “Less Sick” Patients
This article was originally published in The Gray Sheet
Executive Summary
The National Heart Lung and Blood Institute and an interdisciplinary team of experts is trying to develop a multi-device clinical trial to test the benefits of ventricular assist devices in patients with advanced, but not end-stage, heart failure
You may also be interested in...
With Approval Of HeartMate II, Thoratec Aims To Double U.S. Implant Centers
Thoratec expects to double the number of U.S. centers implanting the HeartMate II continuous flowventricular assist device from 40 to 80 by the end of 2008
Ventricular Assist Device Trials Need Redesign, FDA And Advisers Agree
FDA agrees with its advisory panel that it should work with industry to develop better trial designs for left ventricular assist devices
CircuLite Aims To Transform HF Treatment With Miniature Blood Pump
CircuLite, a New Jersey start-up, aims to begin a U.S. clinical trial next year for a new treatment option for chronic heart failure patients